Form 8-K - Current report:
SEC Accession No. 0001104659-18-039210
Filing Date
2018-06-08
Accepted
2018-06-08 16:56:45
Documents
8
Period of Report
2018-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-14700_28k.htm 8-K 87686
2 EX-10.1 a18-14700_2ex10d1.htm EX-10.1 60332
3 EX-10.2 a18-14700_2ex10d2.htm EX-10.2 91617
4 EX-10.3 a18-14700_2ex10d3.htm EX-10.3 55611
5 EX-10.4 a18-14700_2ex10d4.htm EX-10.4 34814
6 EX-10.5 a18-14700_2ex10d5.htm EX-10.5 21513
7 EX-10.6 a18-14700_2ex10d6.htm EX-10.6 33818
8 EX-10.7 a18-14700_2ex10d7.htm EX-10.7 25046
  Complete submission text file 0001104659-18-039210.txt   411855
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 18890139
SIC: 2834 Pharmaceutical Preparations